Relationship between the nature of mucus and crypt multiplicity in aberrant crypt foci in the rat colon.
Aberrant crypt foci (ACF) induced in the distal colon of F344 male rats, 4, 8, 12 and 35 weeks after the first administration of 1, 2-dimethylhydrazine-2HCl (DMH) were examined to determine whether a correlation exists between the nature of goblet cell mucin and the number of crypts (crypt multiplicity) comprising the ACF. According to the ACF score calculated from the results of the qualitative observation of sulfomucins (SuMs) and sialomucins (SiMs), the ACF in the 4th week showed a weak correlation between the nature of the mucus and crypt multiplicity, and the ACF of each class showed similar mucous profiles. From the 8th week, a significant difference (P < 0.01) was recognized between the ACF consisting of 3 crypts or less and those consisting of 4 crypts or more. The proportion of crypts with SiM predominance showed a decrease in the 8th week in the ACF consisting of 1 crypt and in the 12th week in the ACF consisting of 2 or 3 crypts, implying a recovery tendency. The ACF consisting of more than 4 crypts showed little change over time, retaining the tendency of SiM predominance. Ulex europaeus agglutinin-I (UEA-I) lectin-positive crypts appeared in the ACF. This finding was significantly more prominent (P < 0.001) in the ACF with SiM predominance than in the ACF with SuM predominance at each experimental period, and in the 12th week after the first administration of DMH, the incidence of ACF with UEA-I-reactive mucin was decreased in the ACF groups consisting of 3 crypts or less, compared with the ACF groups consisting of 4 or more crypts. These results suggest that the biological quality of mucus in ACF consisting of 4 or more crypts is different from that in ACF consisting of 3 crypts or less. This difference should be considered when ACF are used as an intermediate biomarker of colon cancer.
Uchida
K
K
Yakult Central Institute for Microbiological Research, Kunitachi.
Kado
S
S
Onoue
M
M
Tohyama
K
K
D019813:1,2-Dimethylhydrazine / Q000633:toxicity*; D000818:Animals; D014408:Biomarkers, Tumor; D002273:Carcinogens / Q000633:toxicity*; D003106:Colon / Q000187:drug effects / Q000473:pathology*; D003110:Colonic Neoplasms / Q000139:chemically induced* / Q000473:pathology; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology*; D037102:Lectins; D008297:Male; D009077:Mucins / Q000032:analysis / Q000096:biosynthesis*; D037121:Plant Lectins; D051381:Rats; D011916:Rats, Inbred F344; D052116:Sialomucins; D013997:Time Factors
D014408:Biomarkers, Tumor; D002273:Carcinogens; D037102:Lectins; D009077:Mucins; D037121:Plant Lectins; D052116:Sialomucins; C036850:Ulex europaeus lectins; C012564:sulfomucin; D019813:1,2-Dimethylhydrazine